Finding treatments for advanced multiple sclerosis (MS) has been difficult. But new research may help neurologists identify which drugs are…
Home »
FDA Approves Sarclisa (isatuximab-irfc) in Combination with Carfilzomib and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with…
85% of COVID-19 long-haulers have multiple brain-related symptoms
Many COVID-19 “long haulers” experience at least four lingering neurological symptoms, such as brain fog, headache and the loss of…
Multiple sclerosis may not put you at risk for breast, colorectal cancers
People with multiple sclerosis (MS) may not be at higher risk of developing two of the three cancers that occur…
Study reveals the multiple benefits of physical exercise for people with lupus
A group of researchers, including personnel from the University of Granada (UGR), has recently presented the results of a study…
New antibody technology for monitoring multiple sclerosis patients may have potential in COVID-19 testing
A new study led by Queen Mary University of London has demonstrated the effectiveness of using a novel light technology…
Potential genetic markers of multiple sclerosis severity
In a bid to determine factors linked to the most debilitating forms of multiple sclerosis (MS), Johns Hopkins Medicine researchers…
Bachelor’s Vienna Girardi Reveals Results of Multiple Plastic Surgeries
A new woman! The Bachelor alum Vienna Girardi showed off the results of her multiple plastic surgeries in new photos…
MGUS can progress to multiple myeloma within five years
(HealthDay)—Individuals with low- or intermediate-risk monoclonal gammopathy of undetermined significance (MGUS) can experience progression to multiple myeloma within five years,…
Standing frame intervention improves life for people with multiple sclerosis, research shows
A new study has shown that people in the advanced stage of multiple sclerosis (MS) experience significant improvements in movement…